Pouneh Kermani is a notable inventor based in Great Neck, NY (US). She has made significant contributions to the field of neurotrophin research, holding 2 patents that focus on methods for inhibiting apoptosis through the p75 neurotrophin receptor.

Latest Patents

Her latest patents include a method for inhibiting apoptosis through the p75 neurotrophin receptor. This invention provides an isolated protein comprising a pro-domain of a proneurotrophin, methods for producing the protein, and pharmaceutical compositions containing the isolated protein. Additionally, it offers a nucleic acid molecule that encodes the protein and a vector containing the nucleic acid molecule. The invention further details a method for cleaving a proneurotrophin protein to a mature neurotrophin. It also relates to methods for inducing apoptosis in a cell of a mammal expressing p75 surface receptors or both p75 and trk receptors. The methods include causing the p75 receptor to bind a pharmaceutical composition containing a pro-domain of a proneurotrophin or administering an effective amount of a cleavage-resistant proneurotrophin along with an inhibitor of trk activation. Furthermore, the invention provides a method for inhibiting apoptosis of a cell in a mammal by administering an effective amount of a molecule that inhibits the binding of a proneurotrophin to a p75 receptor. Kits and methods for screening a human for conditions associated with undesired apoptosis are also included.

Career Highlights

Pouneh Kermani is affiliated with Cornell University, where she continues her research and innovation in the field of neurotrophins. Her work has the potential to impact therapeutic approaches for various conditions related to apoptosis.

Collaborations

Some of her notable coworkers include Kenneth K Teng and Barbara L Hempstead, who contribute to her research endeavors.

Conclusion

Pouneh Kermani's innovative work in neurotrophin research exemplifies the importance of scientific advancements in understanding and potentially treating conditions related to apoptosis. Her contributions through her patents reflect her commitment to advancing medical science.